ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is Magnesium the Missing Link in Your Heart Healthy Routine?

A Little Zinc Goes a Long Way

Supplementation with vitamin D associated with improved testosterone, erectile function among middle...

More evidence for calorie restriction’s longevity effect

Vitamin D deficiency increases risk of chronic headache

Wearable biosensors can flag illness, Lyme disease, risk for diabetes; low airplane oxygen

VIDEO: The Best Brain Foods That Help Increase Your Memory!

Iron (And More) For Lasting, Natural Energy

Get the Most From Your Green Tea

Affordable Care Act made cancer screening more accessible for millions, study finds

 
Print Page
Email Article

Stanford Researchers Home in on Huntington's Disease Treatment

  [ 5 votes ]   [ Discuss This Article ]
www.ProHealth.com • February 1, 2002





STANFORD, Calif. - Stanford University Medical Center researchers have discovered a potential treatment for Huntington's disease. By enhancing the brain's natural protective response to the disease, researchers were able to alleviate the uncontrollable tremors and prolong the lives of mice with a neurological disorder that mimics Huntington's. Their finding suggests that a similar treatment strategy may be effective in humans.

"This is exciting because it has implications for therapy," said Lawrence Steinman, MD, professor of neurological sciences and pediatrics and senior author of the study, published in the February issue of Nature Medicine.

Huntington's disease is a hereditary disorder characterized by memory loss, abnormal movement and premature death. It affects 1 in 10,000 people, and children with an affected parent have a 50 percent chance of developing the disease.

An abnormal form of the gene called huntingtin is at the root of the problem. In healthy individuals, the huntingtin gene encodes a protein with 6 to 34 glutamine molecules - one of the essential building blocks of proteins - at one end. When the number of glutamine molecules at the end of the protein exceeds 36, Huntington's disease results. But the normal gene function remains a mystery.

According to earlier research, the brains of Huntington's patients become clogged with clumps of protein called aggregates. The aggregates are made up of the abnormal huntingtin proteins hooked together. The aggregations are formed by the action of an enzyme called transglutaminase and by the tendency of these proteins to stick together.

If the aggregates are the cause of the disease, Steinman reasoned, perhaps the disease could be controlled by preventing the two proteins from clumping into aggregates. He already knew that a compound called cystamine could keep the sticky protein, transglutaminase, under wraps.

So, his former graduate student, Marcela Karpuj, PhD, now a postdoctoral fellow at University of California San Francisco, began treating their sick mice with cystamine injections. The treated mice showed signs of improvement; the tremors and abnormal movements became less severe, and the lifespan of the mice increased by 20 percent on average.

But to the researcher's surprise, the protein aggregates remained unchanged.

"The story, because it is science, took an unexpected turn," Steinman said. "We expected cystamine to inhibit the aggregations."

Paper co-author Mark Becher, chief of neuropathology at the University of New Mexico Health Sciences Center, examined the brains of these mice, and found aggregations were the same after treatment, Steinman said.

This result set the Stanford team off on a "hypothesis-finding expedition." They began to screen the brains of cystamine-treated and untreated mice, looking for any differences in gene expression between the two groups.

The researchers found that mice treated with cystamine had elevated expression of three particularly interesting genes - all of which are known to encode proteins that play a protective role in the brain. These same neuroprotective proteins were found at increased levels in the brains of human Huntington's patients. This finding suggested that the brain makes an unsuccessful attempt to protect itself against the disease.

"It seems the brain under attack has a number of defense mechanisms turned on to sop up toxic brain proteins, lead them away to digestive compartments, and out of the neuron," Steinman said. "This allows the neuron to survive, which is important since mammalian brains are bad at regenerating neurons."

Though these findings suggest that cystamine could someday offer hope to patients with Huntington's disease, the quest for other potentially better compounds will continue.

"Before trying this with humans, we will search for ever more effective and specific compounds," Steinman said. "On the other hand, this is a horrendous, fatal disease. So we will have to see at what pace it will be applied to humans."

In recent years, other compounds have also been reported to extend the lives of mice suffering from Huntington's, Steinman said. Perhaps multiple treatments in combination would have even greater benefits, he added.

Marcela Karpuj, primary author of the study, is optimistic about the results. "I think this is very exciting," she said. "In the future, treatments to raise the levels of neuroprotective proteins could be given to humans and could be therapeutic for other neurodegenerative diseases as well."

Funding for the study was provided by the Hereditary Disease Foundation and the National Institutes of Health.

Stanford University Medical Center integrates research, medical education and patient care at its three institutions - Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children's Hospital. For more information, please visit the Web site of the medical center's Office of News and Public Affairs at http://mednews.stanford.edu.

MEDIA CONTACT: Krista Conger at 650-725-5371 (kristac@stanford.edu)
BROADCAST MEDIA CONTACT: M.A. Malone at 723-6912 or 723-6911 (mamalone@stanford.edu)



Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ Vitamin D3 Extreme™ Energy NADH™ 12.5mg

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health

Natural Remedies

Three-Step Strategy to Reverse Mitochondrial Aging Three-Step Strategy to Reverse Mitochondrial Aging
Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue
Astaxanthin - A Little-Known but Power-Packed Nutrient Astaxanthin - A Little-Known but Power-Packed Nutrient
Block Acid Reflux to Prevent Esophageal Problems! Block Acid Reflux to Prevent Esophageal Problems!
The Remarkable Benefits of Reishi Medicinal Mushrooms The Remarkable Benefits of Reishi Medicinal Mushrooms

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map